Which peptide is a chemical transmitter of the GIT secreted in a paracrine fashion?
What is responsible for clearing and flushing food from the intestinal lumen in the interdigestive period?
What percentage of the blood flow to the liver is supplied by the hepatic artery?
All are TRUE about Gastrin, EXCEPT:
Which of the following is a reflex mediated by the vagus nerve?
What is the approximate size of the bile acid pool in grams?
What is the primary pathology in achalasia cardia?
All of the following are features of the large intestine, EXCEPT?
Which of the following hormones stimulates gastric emptying?
Release of proenzymes from the pancreatic acinar cells is accomplished by which of the following processes?
Explanation: ### Explanation **Correct Answer: C. Somatostatin** **Mechanism and Concept:** In the Gastrointestinal Tract (GIT), regulatory substances are classified based on their mode of delivery to the target cell. **Somatostatin** is the classic example of a **paracrine** peptide. It is secreted by **D cells** in the gastric antrum and duodenal mucosa. Unlike hormones that travel through the blood, paracrine substances diffuse through the interstitial space to act on neighboring cells. Somatostatin acts as the "universal inhibitor" of the GIT; it inhibits the release of gastrin, insulin, glucagon, and pancreatic enzymes, and decreases gastric acid secretion. **Analysis of Incorrect Options:** * **A. Gastrin:** This is a **hormone** secreted by G cells of the antrum into the portal circulation. It travels via the bloodstream to stimulate parietal cells to secrete HCl. * **B. Secretin:** This is a **hormone** secreted by S cells of the duodenum. It travels through the blood to the pancreas to stimulate the release of bicarbonate-rich pancreatic juice. * **D. Histamine:** While histamine acts in a paracrine fashion to stimulate acid secretion, it is **not a peptide**; it is a biogenic amine derived from the amino acid histidine. The question specifically asks for a *peptide*. **NEET-PG High-Yield Pearls:** * **Candidate Paracrines:** Somatostatin and Histamine (Note: Only Somatostatin is a peptide). * **True GI Hormones:** Gastrin, Secretin, Cholecystokinin (CCK), and Gastric Inhibitory Peptide (GIP). * **Neurocrines:** VIP (Vasoactive Intestinal Peptide), GRP (Gastrin Releasing Peptide), and Enkephalins. * **Clinical Correlation:** Octreotide is a synthetic long-acting analog of somatostatin used clinically to treat secretory diarrhea, acromegaly, and bleeding esophageal varices.
Explanation: **Explanation:** The correct answer is **Migrating Motor Complexes (MMC)**. **1. Why MMCs are correct:** The Migrating Motor Complex is a distinct pattern of electromechanical activity observed in the gastrointestinal smooth muscle during the **interdigestive state** (fasting). MMCs occur every 90–120 minutes and consist of intense peristaltic waves that sweep from the stomach to the terminal ileum. Their primary physiological role is to act as an **"intestinal housekeeper,"** clearing the lumen of residual undigested food, desquamated cells, and bacteria. This prevents bacterial overgrowth in the small intestine. The hormone **Motilin**, secreted by M-cells in the duodenum, is the primary mediator of MMCs. **2. Why the other options are incorrect:** * **Gastrin (A):** Primarily stimulates gastric acid secretion and mucosal growth; it is secreted in response to a meal (fed state), not during the interdigestive period. * **Secretin (C):** Released in response to H+ ions in the duodenum; it stimulates pancreatic bicarbonate secretion to neutralize acid. * **CCK (D):** Cholecystokinin is released in response to fats and proteins; it stimulates gallbladder contraction and pancreatic enzyme secretion. Both Secretin and CCK **inhibit** MMCs as the body transitions from the fasting to the fed state. **High-Yield Clinical Pearls for NEET-PG:** * **Phases of MMC:** Phase III is the most active phase (maximal contraction). * **Feeding:** Ingestion of food immediately terminates MMCs and initiates the "fed pattern" (segmentation and peristalsis). * **Clinical Correlation:** Erythromycin acts as a motilin agonist and can be used to treat gastroparesis by stimulating GI motility. * **Vagal Control:** While motilin is the main hormone, the vagus nerve also plays a role in coordinating MMCs.
Explanation: The liver has a unique **dual blood supply**, receiving blood from both the portal vein and the hepatic artery. ### **1. Why 20% is the Correct Answer** The liver receives approximately **25% (range 20–30%)** of its total blood flow via the **hepatic artery**. This blood is highly oxygenated and originates directly from the celiac trunk. Conversely, the **portal vein** supplies the remaining **75% (range 70–80%)** of the blood flow. Crucially, while the hepatic artery provides only ~25% of the total *volume*, it contributes about **50% of the oxygen supply** to the liver because it carries arterial blood with high oxygen saturation compared to the partially deoxygenated blood in the portal vein. ### **2. Analysis of Incorrect Options** * **A (90%):** This is incorrect as no single vessel provides 90% of the flow; the liver is distinct for its balanced dual supply. * **C (40%) & D (60%):** These figures do not align with standard physiological data. While the hepatic artery flow can increase slightly if portal flow is compromised (the "hepatic arterial buffer response"), it rarely reaches these percentages under normal physiological conditions. ### **3. NEET-PG High-Yield Pearls** * **Total Liver Blood Flow:** Approximately **1500 mL/min** (roughly 25% of cardiac output). * **Hepatic Arterial Buffer Response (HABR):** An intrinsic mechanism where a decrease in portal vein flow triggers compensatory vasodilation of the hepatic artery to maintain total hepatic blood flow. * **Oxygenation:** Despite the lower volume, the hepatic artery and portal vein contribute roughly equal amounts of oxygen to the hepatocytes. * **Pressure Dynamics:** The portal vein is a low-pressure system (~8–10 mmHg), while the hepatic artery is a high-pressure system.
Explanation: ### Explanation **Gastrin** is a key gastrointestinal hormone produced primarily by **G cells** in the antrum of the stomach and the duodenum. **Why Option D is the Correct Answer (The False Statement):** The synthesis of gastrin involves several post-translational modifications. The precursor **pro-gastrin** is cleaved to form **glycine-extended gastrin (G-Gly)**. However, G-Gly is not the final functional product; it is an **intermediate** that must undergo further enzymatic conversion (amidation) to become bioactive gastrin. While G-Gly is present in the biosynthetic pathway, it is not the primary "produced" hormone of the gastric mucosa in a functional context, and more importantly, it lacks the biological potency of the amidated forms. **Analysis of Other Options:** * **Option A (True):** Gastrin synthesis begins as **preprogastrin**, which is then cleaved into progastrin and subsequently into various gastrin fragments. * **Option B (True):** The two major circulating forms are **G 17** (Little Gastrin, the main form secreted by the antrum) and **G 34** (Big Gastrin, the main form secreted by the duodenum). * **Option C (True):** All bioactive gastrins share a common **C-terminal amidated tetrapeptide sequence** (Trp-Met-Asp-Phe-NH2). This sequence is essential for binding to the CCK-B receptor and is identical to the terminal sequence of Cholecystokinin (CCK). **High-Yield Clinical Pearls for NEET-PG:** * **Most Potent Stimulus:** Luminal peptides and amino acids (Phenylalanine and Tryptophan). * **Inhibition:** Secretion is inhibited by a luminal pH < 1.5 and by Somatostatin. * **Zollinger-Ellison Syndrome:** A gastrin-secreting tumor (Gastrinoma) leading to hypergastrinemia, causing multiple refractory peptic ulcers and hypertrophy of gastric mucosa. * **Trophic Effect:** Gastrin stimulates the growth of gastric mucosa (ECL cells and Parietal cells).
Explanation: ### Explanation **Correct Option: C. Cephalic phase of gastric secretion** The cephalic phase accounts for approximately 30% of total gastric acid secretion and is triggered by the sight, smell, thought, or taste of food. This phase is entirely mediated by the **Vagus nerve (Cranial Nerve X)**. Vagal stimulation leads to: 1. Direct stimulation of **Parietal cells** via ACh (M3 receptors). 2. Stimulation of **G-cells** via Gastrin-Releasing Peptide (GRP) to release gastrin. 3. Inhibition of **D-cells**, thereby reducing somatostatin (an acid inhibitor). --- ### Why other options are incorrect: * **A. Bile flow from the liver:** While the vagus nerve causes weak contraction of the gallbladder, the primary stimulus for bile flow and gallbladder contraction is the hormone **Cholecystokinin (CCK)**, released in response to fatty acids in the duodenum. * **B. Pancreatic secretion of bicarbonate:** This is primarily mediated by the hormone **Secretin** (the "Nature's Antacid"), which is released from S-cells in the duodenum in response to low pH (<4.5). Vagal stimulation primarily affects enzyme-rich (ecbolic) secretion, not bicarbonate. * **C. Mucous secretion from Brunner's glands:** These glands (located in the duodenum) secrete alkaline mucus primarily in response to **local irritation** of the duodenal mucosa and **Secretin**. While vagal stimulation can increase secretion, it is not the primary mediator compared to the cephalic phase of the stomach. --- ### High-Yield NEET-PG Pearls: * **Vagotomy:** Historically used to treat peptic ulcers; it abolishes the cephalic phase of gastric secretion. * **Sham Feeding:** An experimental method used to study the cephalic phase (food is chewed but not swallowed). * **Gastric Phases:** Cephalic (Vagal/30%), Gastric (Distension/60%), and Intestinal (Hormonal/10%). * **Neurotransmitter:** Note that vagal stimulation of G-cells uses **GRP**, not Acetylcholine; therefore, atropine does not completely block gastrin release.
Explanation: **Explanation:** The correct answer is **4 g (Option D)**. The **bile acid pool** refers to the total amount of bile acids present in the body at any given time, primarily circulating within the enterohepatic circulation. In a healthy adult, this pool size is approximately **2 to 4 grams**. While the liver only synthesizes about 0.2–0.6 g of new bile acids daily to replace those lost in feces, the total pool must be much larger to facilitate fat digestion. **Why 4 g is correct:** To digest a typical meal, the body requires a large amount of bile. Since the pool is only ~4 g, it must circulate **6 to 10 times per day** (enterohepatic circulation). This recycling is highly efficient, with ~95% of bile acids being reabsorbed in the **terminal ileum** and returned to the liver via the portal vein. **Analysis of Incorrect Options:** * **Option A (1 g) & B (2 g):** These values are too low for the average adult pool. A 1–2 g pool would require an impossibly high frequency of cycling to maintain lipid absorption. * **Option C (3 g):** While some texts cite 2–3 g, most standard physiological references (like Guyton and Ganong) and NEET-PG pattern keys recognize **4 g** as the upper limit and the standard representative value for the total pool. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting enzyme:** Cholesterol 7α-hydroxylase converts cholesterol to bile acids. * **Primary Bile Acids:** Cholic acid and Chenodeoxycholic acid (synthesized in the liver). * **Secondary Bile Acids:** Deoxycholic acid and Lithocholic acid (formed by bacterial action in the colon). * **Site of Absorption:** The **terminal ileum** is the most crucial site for active transport of bile salts. Disease here (e.g., Crohn’s disease) leads to bile acid malabsorption and steatorrhea.
Explanation: **Explanation:** **1. Why Inhibitory Neurons are Correct:** Achalasia cardia is a primary esophageal motility disorder characterized by the failure of the Lower Esophageal Sphincter (LES) to relax and the absence of peristalsis. The underlying pathology is the **degeneration of inhibitory neurons** in the **myenteric (Auerbach’s) plexus**. These neurons normally release **Nitric Oxide (NO)** and **Vasoactive Intestinal Peptide (VIP)**, which are essential for relaxing the LES. Their loss leads to an unopposed excitatory tone, resulting in a hypertensive, non-relaxing sphincter. **2. Why Other Options are Incorrect:** * **Excitatory Neurons:** These neurons release Acetylcholine, which causes contraction. In achalasia, while there is a relative imbalance, the *primary* defect is the loss of the inhibitory signals that allow for relaxation. * **Muscles:** The smooth muscle of the esophagus is typically structurally normal in the early stages. The dysfunction is neurogenic, not a primary myopathy. * **Neuromuscular Junction:** This is the site of pathology in conditions like Myasthenia Gravis. Achalasia is a disorder of the enteric nervous system (plexus) within the esophageal wall, not the junction between motor nerves and skeletal muscle. **3. High-Yield Facts for NEET-PG:** * **Classic Triad:** Dysphagia (for both solids and liquids), regurgitation, and weight loss. * **Radiology:** Barium swallow shows the characteristic **"Bird’s Beak"** appearance. * **Gold Standard Diagnosis:** **Esophageal Manometry**, which shows incomplete LES relaxation and aperistalsis. * **Chagas Disease:** Caused by *Trypanosoma cruzi*, it can cause secondary achalasia by destroying the myenteric plexus. * **Histology:** Shows a significant reduction or absence of ganglion cells in the Auerbach’s plexus.
Explanation: **Explanation:** **1. Why Option A is the correct answer (The Exception):** The large intestine secretes **alkaline mucus**, not acidic mucus. This secretion is rich in bicarbonate ions ($HCO_3^-$) and has a pH of approximately 8.0. The alkalinity is crucial because it neutralizes the irritating organic acids produced by bacterial fermentation of undigested carbohydrates. The mucus itself acts as a lubricant to facilitate the passage of feces and provides an adherent medium for holding fecal matter together. **2. Analysis of Incorrect Options:** * **Option B (Mucocutaneous junction):** This is a true feature. The large intestine ends at the anal canal, where the columnar epithelium of the rectum meets the stratified squamous epithelium of the skin at the **pectinate (dentate) line**, forming a mucocutaneous junction. * **Option C (Goblet cells):** This is true. The density of goblet cells increases progressively from the duodenum to the colon. The large intestine has a high concentration of these cells to provide the heavy lubrication required for solidifying stool. * **Option D (Salt and water absorption):** This is a primary function. The proximal half of the colon (absorbing colon) absorbs sodium ($Na^+$) and chloride ($Cl^-$) via active transport, creating an osmotic gradient that allows for the absorption of up to 5–7 liters of water daily. **Clinical Pearls for NEET-PG:** * **Aldosterone Effect:** Aldosterone significantly enhances sodium absorption in the colon, similar to its effect on the renal tubules. * **Potassium Secretion:** Unlike the small intestine, the large intestine actively secretes $K^+$ into the lumen; hence, chronic diarrhea can lead to **hypokalemia**. * **Bacterial Flora:** The colon is the site of Vitamin K and Vitamin $B_{12}$ synthesis by commensal bacteria.
Explanation: **Explanation:** The regulation of gastric emptying is a balance between stimulatory signals from the stomach and inhibitory signals from the duodenum (the enterogastric reflex). **Why Gastrin is correct:** Gastrin is primarily secreted by the G-cells of the antrum in response to stomach distension and the presence of proteins. Its primary roles are stimulating gastric acid secretion and mucosal growth. Crucially, gastrin **increases the force of antral contractions** and relaxes the pyloric sphincter, thereby **promoting gastric emptying**. It is the only major GI hormone that stimulates this process. **Why the other options are incorrect:** The remaining options are "Enterogastrones"—hormones released by the duodenum to **slow down** gastric emptying, ensuring the small intestine has enough time to neutralize acid and digest fats/proteins. * **Secretin (B):** Released in response to low pH in the duodenum; it inhibits gastric motility and acid secretion to protect the duodenal mucosa. * **Cholecystokinin (CCK) (C):** Released in response to fat and proteins; it is the **most potent inhibitor** of gastric emptying, allowing more time for fat emulsification. * **Gastric Inhibitory Peptide (GIP) (D):** Now often called Glucose-dependent Insulinotropic Peptide, it inhibits gastric motility and acid secretion while stimulating insulin release. **High-Yield Clinical Pearls for NEET-PG:** * **Fastest to Slowest Emptying:** Carbohydrates > Proteins > Fats (Fats are slowest due to CCK release). * **Vagus Nerve:** Stimulates gastric emptying via parasympathetic input. * **Dumping Syndrome:** Occurs post-gastrectomy due to the loss of the pyloric "gatekeeper" function, leading to rapid gastric emptying and osmotic diarrhea.
Explanation: ### Explanation **Correct Option: A. Exocytosis** Pancreatic acinar cells synthesize digestive enzymes (as inactive proenzymes or zymogens) on the rough endoplasmic reticulum. These are packaged into membrane-bound **zymogen granules** within the Golgi apparatus. Upon stimulation by **Cholecystokinin (CCK)** or acetylcholine (vagal stimulation), these granules migrate to the apical membrane. The granule membrane fuses with the plasma membrane, releasing the contents into the acinar lumen. This process of releasing intracellular vesicle contents into the extracellular space is called **exocytosis**. **Why Incorrect Options are Wrong:** * **B. Transcytosis:** This involves the transport of macromolecules across the interior of a cell (entry via endocytosis on one side and exit via exocytosis on the other). It is common in capillary endothelium but not for enzyme secretion. * **C. Apoptosis:** This is programmed cell death. While it occurs in the pancreas during chronic pathology or remodeling, it is not a physiological mechanism for enzyme secretion. * **D. Endocytosis:** This is the process of taking substances *into* the cell by engulfing them in a vesicle. It is the functional opposite of the secretion process described. **High-Yield Clinical Pearls for NEET-PG:** * **Stimulus for Secretion:** CCK is the most potent stimulator of enzyme-rich pancreatic secretion, while **Secretin** stimulates bicarbonate-rich (aqueous) secretion. * **Protective Mechanism:** Enzymes are stored as inactive zymogens (e.g., trypsinogen) to prevent **autodigestion** of the pancreas. * **Trypsinogen Activation:** It is converted to active trypsin by the enzyme **enterokinase** (enteropeptidase) located on the duodenal brush border. Once formed, trypsin autocatalytically activates other proenzymes.
Gastrointestinal Motility
Practice Questions
Gastrointestinal Secretions
Practice Questions
Digestion and Absorption
Practice Questions
Gastrointestinal Hormones
Practice Questions
Hepatobiliary Physiology
Practice Questions
Pancreatic Exocrine Function
Practice Questions
Gastrointestinal Circulation
Practice Questions
Intestinal Immune System
Practice Questions
Gut Microbiome
Practice Questions
Regulation of Food Intake
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free